October 12, 2017 09:06 AM EDT
Pharma

Karyopharm bags a $193M Asian deal for se­linex­or and fol­lowup drug, shares jump

Arsalan Arif

Founder

Karyopharm Ther­a­peu­tics $KP­TI has inked a re­gion­al Asian deal for its late-stage can­cer ther­a­py se­linex­or and a fol­low-up com­pound it has in the pipeline. Ono …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Up­dat­ed: CEO of Unit­ed­Health in­sur­ance unit shot and killed in New York in what po­lice call ‘a brazen, tar­get­ed ...

Lil­ly beats No­vo in bell­wether head-to-head weight loss study

As 23andMe strug­gles, an­oth­er ge­net­ic test­ing com­pa­ny bets on drug dis­cov­ery

GSK makes an­oth­er ADC deal, this time with BioN­Tech's part­ner Du­al­i­ty­Bio

Lil­ly drops body mass ranges from FDA la­bel for weight loss drug

On heels of Mar­i­Tide da­ta, Dan­ish obe­si­ty biotech dis­clos­es €80M Se­ries A

A service from the Financial Times